2D41

ICD-11 MMS 2026-01

Unspecified carcinoma of unspecified site

Coding note from above levels

For use of this category, reference should be made to the mortality coding rules and guidelines in the Reference Guide.

Index terms

  • Unspecified carcinoma of unspecified site
  • carcinoma NOS
  • carcinoma of unspecified primary site
Show allHide
  • Carcinoma in polyp of unspecified site
  • Carcinoma with apocrine metaplasia of unspecified site
  • Carcinoma with cartilaginous metaplasia of unspecified site
  • Carcinoma with osseous metaplasia of unspecified site
  • Carcinoma with productive fibrosis of unspecified site
  • Carcinoma with spindle cell metaplasia of unspecified site
  • Carcinoma with squamous metaplasia of unspecified site
  • Metastatic carcinoma [primary carcinoma spreading elsewhere]

Exclusions from above levels

  • http://id.who.int/icd/entity/1965082709 – Malignant mesenchymal neoplasms
  • http://id.who.int/icd/entity/879154182 – Neoplasms of central nervous system or related structures
  • http://id.who.int/icd/entity/944754984 – Neoplasms of haematopoietic or lymphoid tissues

Sibling codes

  • 2D40 – Adenocarcinoma of unspecified site
  • 2D42 – Malignant neoplasms of ill-defined sites
  • 2D43 – Malignant neoplasms of independent, multiple primary sites
  • 2D44 – Malignant neoplasm, primary site unknown, so stated
  • 2D4Y – Other specified malignant neoplasms of unspecified primary sites
  • 2D4Z – Unspecified malignant neoplasms of unspecified sites

Foundation entity

Unspecified carcinoma of unspecified site – http://id.who.int/icd/entity/1467715547

Allowed postcoordination axes

Part of: 02: Neoplasms